Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients with mCRPC By Ogkologos - August 27, 2025 373 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-3 study Source RELATED ARTICLESMORE FROM AUTHOR Patient Guide in Testicular Cancer Now Available Also in Italian Adding 177Lu-PNT2002 to SBRT Significantly Improves PFS in Patients with Oligorecurrent Hormone-Sensitive Prostate Cancer A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer MOST POPULAR EMA Recommends Granting a Marketing Authorisation for Datopotamab Deruxtecan February 20, 2025 Coping With the Difficult Times of Cancer Survivorship Through My “Bucket... August 1, 2023 FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory... March 18, 2021 Boy Asks Mom Fighting Cancer To Take Off Her Turban So... May 4, 2020 Load more HOT NEWS FDA Approves Nivolumab for Adjuvant Treatment of Urothelial Carcinoma Genetic Cancer Screenings in Younger Women May Be Cost-Effective and Lead... Thinking outside the box to tackle an aggressive children’s cancer Optimistic targets aren’t enough – this is what we need to...
